[go: up one dir, main page]

FI52335C - Process for the preparation of therapeutically active ethylamine derivatives. - Google Patents

Process for the preparation of therapeutically active ethylamine derivatives.

Info

Publication number
FI52335C
FI52335C FI670710A FI71067A FI52335C FI 52335 C FI52335 C FI 52335C FI 670710 A FI670710 A FI 670710A FI 71067 A FI71067 A FI 71067A FI 52335 C FI52335 C FI 52335C
Authority
FI
Finland
Prior art keywords
preparation
therapeutically active
ethylamine derivatives
ethylamine
derivatives
Prior art date
Application number
FI670710A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI52335B (en
Inventor
Hans Lettre
Kurt Stach
Werner Winter
Wolfgang Schaumann
Annemarie Ribbentrop
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of FI52335B publication Critical patent/FI52335B/fi
Publication of FI52335C publication Critical patent/FI52335C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/90—Xanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI670710A 1966-03-11 1967-03-09 Process for the preparation of therapeutically active ethylamine derivatives. FI52335C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0086165 1966-03-11

Publications (2)

Publication Number Publication Date
FI52335B FI52335B (en) 1977-05-02
FI52335C true FI52335C (en) 1977-08-10

Family

ID=6983250

Family Applications (1)

Application Number Title Priority Date Filing Date
FI670710A FI52335C (en) 1966-03-11 1967-03-09 Process for the preparation of therapeutically active ethylamine derivatives.

Country Status (6)

Country Link
AT (1) AT272306B (en)
CH (1) CH499487A (en)
FI (1) FI52335C (en)
FR (1) FR1513909A (en)
GB (1) GB1129029A (en)
NL (1) NL152845B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130988C (en) 1966-07-21 Boehringer Mannheim Gmbh
DE3009045A1 (en) 1980-03-08 1981-09-24 Basf Ag, 6700 Ludwigshafen 10-SUBSTITUTED 5-CYANMETHYLENE-10,11-DIHYDRO-DIBENZO- (A, D) -CYCLOHEPTENE
DE3009034A1 (en) * 1980-03-08 1981-09-24 Basf Ag, 6700 Ludwigshafen 10-SUBSTITUTED 5-CYANMETHYLENE DIBENZO (A, D) -CYCLOHEPTNE
FR2512024A1 (en) * 1981-08-27 1983-03-04 Adir TRICYCLIC ETHERS, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0226730B1 (en) * 1985-10-15 1994-03-02 Abbott Laboratories Compounds and assay for tricyclic antidepressants
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en) 1993-02-08 2001-04-03 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6750244B2 (en) * 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE4443892A1 (en) * 1994-12-09 1996-06-13 Bayer Ag 4- (Quinolin-2-yl-methoxy) phenyl acetic acid derivatives
WO1998056752A1 (en) * 1997-06-11 1998-12-17 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6919473B2 (en) 2002-09-17 2005-07-19 Cph Innovations Corporation Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US7544350B2 (en) 2002-11-22 2009-06-09 Hallstar Innovations Corp. Method of decreasing the UV light degradation of polymers
US7534420B2 (en) 2004-02-25 2009-05-19 Hallstar Innovations Corp. Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostablizing properties, compositions containing same, and methods of using the same
US7235587B2 (en) 2004-07-01 2007-06-26 Cph Innovations Corporation Diesters containing two crylene or fluorene moieties, sunscreen compositions containing the same, and methods of photostabilizing a sunscreen compositions containing the same
US8158678B2 (en) 2005-04-07 2012-04-17 Cph Innovations Corp. Photoabsorbing, highly conjugated compounds of cyanoacrylic esters, sunscreen compositions and methods of use
US10930937B2 (en) * 2016-11-23 2021-02-23 Lockheed Martin Energy, Llc Flow batteries incorporating active materials containing doubly bridged aromatic groups

Also Published As

Publication number Publication date
FR1513909A (en) 1968-02-16
CH499487A (en) 1970-11-30
NL6703314A (en) 1967-09-12
NL152845B (en) 1977-04-15
FI52335B (en) 1977-05-02
AT272306B (en) 1969-07-10
GB1129029A (en) 1968-10-02

Similar Documents

Publication Publication Date Title
FI48590C (en) Process for the preparation of therapeutically useful azaspiroalkandion compounds.
FI48460C (en) Process for the preparation of pharmacologically active novel amino-dihalophenylethylamines.
FI42712C (en) Process for the preparation of therapeutically active biphenylalkane derivatives
FI49035C (en) Process for the preparation of therapeutically useful 2-bromo-alpha-gocryptine.
FI49497C (en) Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.
FI52335C (en) Process for the preparation of therapeutically active ethylamine derivatives.
FI49958C (en) Process for the preparation of therapeutically active aminoguanidine derivatives.
FI50707C (en) Process for the preparation of new pharmacologically active hydroxycyclohexylamines.
FI46373C (en) A process for the preparation of new therapeutically useful derivatives of phenylaminopropane.
FI49512C (en) Process for the preparation of novel therapeutically active s-triazinyl-piperazine derivatives.
FI45447C (en) Process for the preparation of therapeutically active imidazole derivatives
FI47365C (en) Process for the preparation of new therapeutically active indolder t.
FI52857C (en) Process for the preparation of therapeutically active amidoximes.
FI45041C (en) Process for the preparation of therapeutically useful pyrrole derivatives.
FI48083C (en) Process for the preparation of new therapeutically active imidazole derivatives
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
FI47881C (en) Process for the preparation of therapeutically active substituted phenylacetamides
FI46961C (en) Process for the preparation of therapeutically active 5-nitroimidazole bamates
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
FI48576C (en) Process for the preparation of therapeutically active alpha-fluoromalic acid derivatives.
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.
FI48724C (en) Process for the preparation of N-carbamoyloxyphenyl carbamates.
FI45045C (en) Process for the preparation of novel therapeutically active 5-nitro-2-furyl-isoxazole derivatives.
FI49162C (en) Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives.